COMMUNIQUÉS West-GlobeNewswire

Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
12/08/2019
The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE [...]
Evolus Reports Second Quarter 2019 Financial Results
12/08/2019
Launched Jeuveau ® in the United States on May 15 Jeuveau ® Experience Treatment (J.E.T.) Program Exceeds Expectations Generated $2.3 Million in Jeuveau ® Net Revenue in Q2 2019 NEWPORT BEACH, Calif., Aug. 12, 2019 ( [...]
C-RAD and Mevion Release Integration for Improved Treatment Quality in Proton Therapy
12/08/2019
C-RAD and Mevion Medical Systems â announced today the integration between the C-RAD Catalyst PT™ and the MEVION S250i Proton Therapy System ® . The union of both products supports a seamless workflow with uninterrupted [...]
New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
12/08/2019
Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of life GAITHERSBURG, Md., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company [...]
Microbix Reports Results for Q3 Fiscal 2019
12/08/2019
Q3 Sales of $3.1 Million and $9.8 Million Year-To-Date TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for [...]
Applied Therapeutics Reports Second Quarter 2019 Financial Results
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today [...]
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
12/08/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Kane Biotech Strengthens Team with New Additions in Animal Health and Quality Assurance
12/08/2019
WINNIPEG, Manitoba, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Acacia Pharma Group plc: Notice of Interim Results
12/08/2019
Cambridge, UK and Indianapolis, US – 12 August 2019: Acacia Pharma Group plc (“Acacia Pharma”, the "Company”, the “Group”), (EURONEXT: ACPH), a pharmaceutical company developing and commercialising hospital products for [...]
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
12/08/2019
Reported that NYX-2925 met primary and secondary endpoints in Phase 2 fibromyalgia study On track to initiate three additional Phase 2 studies in 2H 2019 across pipeline of CNS product candidates Conference call today [...]
Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
12/08/2019
- Successful IPO provides more than $100 million in gross proceeds to advance leading oral integrin development pipeline and MInT discovery platform - Company remains on track to file INDs for its two lead programs [...]
BriaCell Appoints Richard J. Berman to Board of Directors
12/08/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Mesoblast Appoints Leading Pharmaceutical Industry Executive as Chief Medical Officer
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, is pleased to announce the appointment of Dr Fred Grossman as Chief [...]
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
12/08/2019
Sunnyvale, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has been approved by a leading Medicare Administrative Contractor (MAC) on behalf of the [...]
Transactions under Novozymes’ stock buyback program
12/08/2019
Please read the full announcement in the attached PDF Attachment 2019_30_Stock_Buybackprogram_EN
Share buy-back week 32/2019
12/08/2019
Announcement 12 August 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Aino Health interim report January-June 2019
12/08/2019
12 August 2019 Aino Health interim report January-June 2019 - Increased net sales, improved profit, net sales and cash flow, the business model is showing results April–June 2019 • Net sales increased by 18 percent to [...]
In July revenues increased by 14%, significant growth in all the main markets
12/08/2019
JSC Olainfarm preliminary consolidated results for July 2019 indicate that revenues increased by 14% compared to the same month last year and reached 9.5 million euro. At the same time consolidated results for the first [...]
Notice of Nexstim Plc's Half-Yearly Report H1 2019
12/08/2019
Company announcement, Helsinki, 12 August 2019 at 9.00 am (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), the targeted neuromodulation company developing and marketing pioneering navigated [...]

Pages